Arcus Biosciences (RCUS)
Arcus Biosciences (RCUS) stock research: performance, analysts' price targets, earnings, revenue and margins, technicals and insider trades.
- RCUS last traded at $15.50 on 2026-11-20, -1.77% for the session.
- Arcus Biosciences: market cap $2.23B, revenue $100.00M over the last four quarters.
- Over the past year RCUS returned -23.34%, with a year-to-date return of -34.96%.
RCUS edges higher as biotech investors weigh pipeline progress
Arcus Biosciences is up 1.0% today, broadly in step with a stronger market, but the shares remain under pressure after falling 10.5% over the past week. Traders are weighing its cancer-drug pipeline progress against a steep recent decline.
Published 2026-11-19 15:01:34 UTC.